论文部分内容阅读
AIM: To investigate the association of receptor for advanced glycation end products(RAGE) G82S and vascular endothelial growth factor(VEGF)-634 G/C gene polymorphisms with diabetic retinopathy(DR).METHODS: Our cross-sectional study included 61 diabetic patients, 12 of them had proliferative diabetic retinopathy(PDR), 15 had non proliferative diabetic retinopathy(NPDR), 34 had no diabetic retinopathy(NDR)and 61 healthy controls. Participants were tested for RAGE G82S and VEGF-634 G/C polymorphisms by polymerase chain reaction-restriction fragment length polymorphism.RESULTS: We found a significant association between VEGF-634 G/C polymorphism and PDR as PDR patients had increased incidence of VEGF-634 CC genotype compared to NDR patients [odds ratio for CC vs(GC +GG)=6.5, 95% CI=1.5-27.8, P =0.021]. Also VEGF-634 CC genotype and C allele were significantly higher in the PDR than in NPDR patients, which is a novel finding in our study(P =0.024, 0.009 respectively). The mean triglycerides level was significantly higher in diabetic patients with CC genotype(P =0.01) as compared to patients with other genotypes. All cases and control subjects were of the same heterozygous RAGE 82G/S genotype.CONCLUSION: Patients carrying VEGF-634 C polymorphism have a higher risk of PDR development,so VEGF-634 G/C polymorphism could be used as a predictive marker for PDR in diabetic patients. We could not find a significant association between RAGE G82S polymorphism and DR.
AIM: To investigate the association of receptor for advanced glycation end products (RAGE) G82S and vascular endothelial growth factor (VEGF) -634 G / C gene polymorphisms with diabetic retinopathy (DR). METHODS: Our cross-sectional study included 61 diabetic patients , 12 of them had proliferative diabetic retinopathy (PDR), 15 had non proliferative diabetic retinopathy (NPDR), 34 had no diabetic retinopathy (NDR) and 61 healthy controls. Participants were tested for RAGE G82S and VEGF-634 G / C polymorphisms by PCR chain reaction-restriction fragment length polymorphism. RESULTS: We found a significant association between VEGF-634 G / C polymorphism and PDR as PDR patients had increased incidence of VEGF-634 CC genotype compared to NDR patients [odds ratio for CC vs (GC + GG) = 6.5, 95% CI = 1.5-27.8, P = 0.021] Also VEGF-634 CC genotype and C allele were significantly higher in the PDR than in NPDR patients, which is a novel finding in our study (P = 0.024, 0.009 respectively). The mean triglycerides level was significantly higher in diabetic patients with CC genotype (P = 0.01) as compared to patients with other genotypes. All cases and control subjects were the same heterozygous RAGE 82G / S genotype. CONCLUSION: Patients carrying VEGF-634 C polymorphism have a higher risk of PDR development, so VEGF-634 G / C polymorphism could be used as a predictive marker for PDR in diabetic patients. We could not find a significant association between RAGE G82S polymorphism and DR.